Iovance Biotherapeutics, Inc.
$3.69B- Market cap
- $3.98B
- Debt
- +$1.00M
- Cash
- −$296.98M
Capital structure 100% equity / 0% debt · EV / Revenue 13.99x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
IOVA · current priceP/S 15.11x
$8.79Latest market snapshot
Implied fair value · at MKC's multiple
$1.1986.4% below market
0.58 IOVA revenue / share×2.05x MKC P/S=$1.19
Market $8.79Implied $1.19
MKC · current priceP/S 2.05x
$52.08Latest market snapshot
Implied fair value · at IOVA's multiple
$384.95639.2% above market
25.48 MKC revenue / share×15.11x IOVA P/S=$384.95
Market $52.08Implied $384.95